Projects per year
Personal profile
Research interests
Biotechnology - Molecular mechanisms of neurodegeneration
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
Education/Academic qualification
PhD in Neuroscience, PhD, University of Cambridge
2001
Fingerprint
Dive into the research topics where Kenny K CHUNG is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
The Role of Relaxin in Alleviating Type 2 Diabetes Mellitus Symptoms and Providing Neuroprotection Against Parkinson’s Disease.
CHUNG, K. K. (PI), TSIM, K. W. K. (CoI) & YUE, S. (CoI)
1/11/22 → 31/10/24
Project: Research
-
A Stem Cell Approach to Dissect the Molecular Basis of Neurodegenerative Diseases
CHUNG, K. K. (CoI), WU, Z. (CoPI), FU, K. Y. (CoPI), IP, N.Y.-Y. (PI), TSIM, K. W. K. (CoI), WONG, Y. H. (CoPI), FENG, B. (CoI), QU, J. (CoPI), HE, J. (CoI), XIA, J. (CoPI), LAI, K. O. (CoPI), ZHANG, M. (CoPI), QI, R. Z. (CoPI), CHEUNG, T. (CoPI), YUNG, W. H. (CoPI), WEN, Z. (CoPI) & IP, J. P. K. (CoI)
RGC - Theme-based Research Scheme
1/01/19 → 31/12/24
Project: Research
-
The establishment of a novel Parkinson's disease mouse model by conditional expression of aggregation-prone alpha-synuclein in dopaminergic neurons
CHUNG, K. K. (PI)
1/01/18 → 30/06/21
Project: Research
-
Age-dependent alpha-synuclein aggregation and Lewy body formation in Parkinson's disease
Sung, C. C. & Chung, K. K. K., 1 Dec 2025, In: Neural Regeneration Research. 20, 12, p. 3533-3534 2 p.Research output: Contribution to journal › Journal Article › peer-review
3 Citations (Scopus) -
一種天然蛋白分子在製備抗帕金森氏症候群的藥物中的應用 Application of a natural protein molecule in the preparation of drugs against Parkinson's syndrome
TSIM, K. W. K., CHUNG, K. K. K., SUNG, C. C., LIN, S. & YU, S., 2025Research output: Other contribution › peer-review
-
The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation
Li, J., Ng, K. W., Sung, C. C. & Chung, K. K. K., Jul 2024, In: Journal of Neurochemistry. 168, 7, p. 1215-1236 22 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access4 Citations (Scopus) -
The role of polo-like kinases 2 in the proteasomal and lysosomal degradation of alpha-synuclein in neurons
Sung, C. C., Lam, W. Y. & Chung, K. K. K., Oct 2024, In: FASEB Journal. 38, 20, e70121.Research output: Contribution to journal › Journal Article › peer-review
1 Citation (Scopus) -
一种天然蛋白分子在制备抗帕金森综合征的药物中的应用
CHUNG, K. K. K. (Inventor), LIN, S. (Inventor), TSIM, K. W. K. (Key Inventor), SUNG, C. C. (Inventor) & YUE, S. (Inventor), 20 Dec 2024, IPC No. C07K 19/00, A61K 38/17, A61P 25/16, A61P 29/00, A61P 39/06, 11 Oct 2024, Priority date 11 Oct 2024Research output: Patent